Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Operating activities
Net income	$ 459.0	$ 414.7
Loss from discontinued operations, net of tax	0.2	0.1
Adjustments to reconcile net income from continuing operations to net cash provided by (used for) operating activities
Equity income of unconsolidated subsidiaries	(1.7)	(2.1)
Depreciation	45.3	44.3
Amortization	40.4	41.5
Deferred income taxes	3.6	(45.0)
Share-based compensation	26.3	21.3
Asset impairment and write-offs	9.3	6.2
Gain on sale of assets	0.0	(3.4)
Changes in assets and liabilities, net of effects of business acquisitions
Accounts receivable	66.2	23.9
Inventories	30.1	67.8
Other current assets	5.0	(14.7)
Accounts payable	7.3	(63.8)
Employee compensation and benefits	(8.0)	11.7
Other current liabilities	(19.7)	(0.2)
Other non-current assets and liabilities	17.1	0.0
Net cash provided by operating activities of continuing operations	680.4	502.3
Net cash used for operating activities of discontinued operations	(0.2)	(1.6)
Net cash provided by operating activities	680.2	500.7
Investing activities
Capital expenditures	(51.7)	(54.8)
Proceeds from sale of property and equipment	0.4	5.4
Payments upon the settlement of net investment hedges	(16.4)	0.0
Acquisitions, net of cash acquired	0.0	(0.6)
Other	(0.5)	4.1
Net cash used for investing activities	(68.2)	(45.9)
Financing activities
Net repayments of revolving long-term debt	0.0	(320.0)
Repayments of long-term debt	(362.5)	(6.3)
Shares issued to employees, net of shares withheld	16.8	9.0
Repurchases of ordinary shares	(100.0)	0.0
Dividends paid	(114.3)	(108.9)
Net cash used for financing activities	(560.0)	(426.2)
Effect of exchange rate changes on cash and cash equivalents	(4.2)	(0.5)
Change in cash and cash equivalents	47.8	28.1
Cash and cash equivalents, beginning of period	170.3	108.9
Cash and cash equivalents, end of period	$ 218.1	$ 137.0